Global NGS Based Diagnostics Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global NGS Based Diagnostics market size was valued at US$ million in 2023. With growing demand in downstream market, the NGS Based Diagnostics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global NGS Based Diagnostics market. NGS Based Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of NGS Based Diagnostics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the NGS Based Diagnostics market.
Next generation sequencing (NGS) based diagnostics are the medical devices used for diagnosis of various conditions using advanced generation sequencing platforms.
North America is currently leading the market due to the research and innovations and presence of maximum numbers of players. Europe is following America. Rising caseload of cancer, incidence of drug-resistant infectious diseases in Asian and African countries have created a huge demand of such technologies. Hence, market will grow at a fast pace in these regions.
Key Features:
The report on NGS Based Diagnostics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the NGS Based Diagnostics market. It may include historical data, market segmentation by Type (e.g., DNA Sequencing, RNA Sequencing), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the NGS Based Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the NGS Based Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the NGS Based Diagnostics industry. This include advancements in NGS Based Diagnostics technology, NGS Based Diagnostics new entrants, NGS Based Diagnostics new investment, and other innovations that are shaping the future of NGS Based Diagnostics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the NGS Based Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for NGS Based Diagnostics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the NGS Based Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting NGS Based Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the NGS Based Diagnostics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the NGS Based Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the NGS Based Diagnostics market.
Market Segmentation:
NGS Based Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global NGS Based Diagnostics market size was valued at US$ million in 2023. With growing demand in downstream market, the NGS Based Diagnostics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global NGS Based Diagnostics market. NGS Based Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of NGS Based Diagnostics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the NGS Based Diagnostics market.
Next generation sequencing (NGS) based diagnostics are the medical devices used for diagnosis of various conditions using advanced generation sequencing platforms.
North America is currently leading the market due to the research and innovations and presence of maximum numbers of players. Europe is following America. Rising caseload of cancer, incidence of drug-resistant infectious diseases in Asian and African countries have created a huge demand of such technologies. Hence, market will grow at a fast pace in these regions.
Key Features:
The report on NGS Based Diagnostics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the NGS Based Diagnostics market. It may include historical data, market segmentation by Type (e.g., DNA Sequencing, RNA Sequencing), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the NGS Based Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the NGS Based Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the NGS Based Diagnostics industry. This include advancements in NGS Based Diagnostics technology, NGS Based Diagnostics new entrants, NGS Based Diagnostics new investment, and other innovations that are shaping the future of NGS Based Diagnostics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the NGS Based Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for NGS Based Diagnostics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the NGS Based Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting NGS Based Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the NGS Based Diagnostics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the NGS Based Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the NGS Based Diagnostics market.
Market Segmentation:
NGS Based Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- DNA Sequencing
- RNA Sequencing
- Whole Genome Sequencing
- Whole Exome Sequencing
- Other
- Hospitals
- Clinics
- Academics/Research Institutions
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Janssen
- Roche
- Qiagen
- ThermoFisher Scientific
- Oxford Gene Technology
- Illumina
- Pacific Biosciences
- Paradigm Diagnostics
- Innogene Kalbiotech
- Admera Health
- AITbiotech
- Centogene
- Phalanx Biotech Group
- iGenomX
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global NGS Based Diagnostics Market Size 2019-2030
2.1.2 NGS Based Diagnostics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 NGS Based Diagnostics Segment by Type
2.2.1 DNA Sequencing
2.2.2 RNA Sequencing
2.2.3 Whole Genome Sequencing
2.2.4 Whole Exome Sequencing
2.2.5 Other
2.3 NGS Based Diagnostics Market Size by Type
2.3.1 NGS Based Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global NGS Based Diagnostics Market Size Market Share by Type (2019-2024)
2.4 NGS Based Diagnostics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Academics/Research Institutions
2.5 NGS Based Diagnostics Market Size by Application
2.5.1 NGS Based Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global NGS Based Diagnostics Market Size Market Share by Application (2019-2024)
3 NGS BASED DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 NGS Based Diagnostics Market Size Market Share by Players
3.1.1 Global NGS Based Diagnostics Revenue by Players (2019-2024)
3.1.2 Global NGS Based Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global NGS Based Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NGS BASED DIAGNOSTICS BY REGIONS
4.1 NGS Based Diagnostics Market Size by Regions (2019-2024)
4.2 Americas NGS Based Diagnostics Market Size Growth (2019-2024)
4.3 APAC NGS Based Diagnostics Market Size Growth (2019-2024)
4.4 Europe NGS Based Diagnostics Market Size Growth (2019-2024)
4.5 Middle East & Africa NGS Based Diagnostics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas NGS Based Diagnostics Market Size by Country (2019-2024)
5.2 Americas NGS Based Diagnostics Market Size by Type (2019-2024)
5.3 Americas NGS Based Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC NGS Based Diagnostics Market Size by Region (2019-2024)
6.2 APAC NGS Based Diagnostics Market Size by Type (2019-2024)
6.3 APAC NGS Based Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe NGS Based Diagnostics by Country (2019-2024)
7.2 Europe NGS Based Diagnostics Market Size by Type (2019-2024)
7.3 Europe NGS Based Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa NGS Based Diagnostics by Region (2019-2024)
8.2 Middle East & Africa NGS Based Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa NGS Based Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NGS BASED DIAGNOSTICS MARKET FORECAST
10.1 Global NGS Based Diagnostics Forecast by Regions (2025-2030)
10.1.1 Global NGS Based Diagnostics Forecast by Regions (2025-2030)
10.1.2 Americas NGS Based Diagnostics Forecast
10.1.3 APAC NGS Based Diagnostics Forecast
10.1.4 Europe NGS Based Diagnostics Forecast
10.1.5 Middle East & Africa NGS Based Diagnostics Forecast
10.2 Americas NGS Based Diagnostics Forecast by Country (2025-2030)
10.2.1 United States NGS Based Diagnostics Market Forecast
10.2.2 Canada NGS Based Diagnostics Market Forecast
10.2.3 Mexico NGS Based Diagnostics Market Forecast
10.2.4 Brazil NGS Based Diagnostics Market Forecast
10.3 APAC NGS Based Diagnostics Forecast by Region (2025-2030)
10.3.1 China NGS Based Diagnostics Market Forecast
10.3.2 Japan NGS Based Diagnostics Market Forecast
10.3.3 Korea NGS Based Diagnostics Market Forecast
10.3.4 Southeast Asia NGS Based Diagnostics Market Forecast
10.3.5 India NGS Based Diagnostics Market Forecast
10.3.6 Australia NGS Based Diagnostics Market Forecast
10.4 Europe NGS Based Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany NGS Based Diagnostics Market Forecast
10.4.2 France NGS Based Diagnostics Market Forecast
10.4.3 UK NGS Based Diagnostics Market Forecast
10.4.4 Italy NGS Based Diagnostics Market Forecast
10.4.5 Russia NGS Based Diagnostics Market Forecast
10.5 Middle East & Africa NGS Based Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt NGS Based Diagnostics Market Forecast
10.5.2 South Africa NGS Based Diagnostics Market Forecast
10.5.3 Israel NGS Based Diagnostics Market Forecast
10.5.4 Turkey NGS Based Diagnostics Market Forecast
10.5.5 GCC Countries NGS Based Diagnostics Market Forecast
10.6 Global NGS Based Diagnostics Forecast by Type (2025-2030)
10.7 Global NGS Based Diagnostics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Janssen
11.1.1 Janssen Company Information
11.1.2 Janssen NGS Based Diagnostics Product Offered
11.1.3 Janssen NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Janssen Main Business Overview
11.1.5 Janssen Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche NGS Based Diagnostics Product Offered
11.2.3 Roche NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Qiagen
11.3.1 Qiagen Company Information
11.3.2 Qiagen NGS Based Diagnostics Product Offered
11.3.3 Qiagen NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Qiagen Main Business Overview
11.3.5 Qiagen Latest Developments
11.4 ThermoFisher Scientific
11.4.1 ThermoFisher Scientific Company Information
11.4.2 ThermoFisher Scientific NGS Based Diagnostics Product Offered
11.4.3 ThermoFisher Scientific NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 ThermoFisher Scientific Main Business Overview
11.4.5 ThermoFisher Scientific Latest Developments
11.5 Oxford Gene Technology
11.5.1 Oxford Gene Technology Company Information
11.5.2 Oxford Gene Technology NGS Based Diagnostics Product Offered
11.5.3 Oxford Gene Technology NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Oxford Gene Technology Main Business Overview
11.5.5 Oxford Gene Technology Latest Developments
11.6 Illumina
11.6.1 Illumina Company Information
11.6.2 Illumina NGS Based Diagnostics Product Offered
11.6.3 Illumina NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Illumina Main Business Overview
11.6.5 Illumina Latest Developments
11.7 Pacific Biosciences
11.7.1 Pacific Biosciences Company Information
11.7.2 Pacific Biosciences NGS Based Diagnostics Product Offered
11.7.3 Pacific Biosciences NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Pacific Biosciences Main Business Overview
11.7.5 Pacific Biosciences Latest Developments
11.8 Paradigm Diagnostics
11.8.1 Paradigm Diagnostics Company Information
11.8.2 Paradigm Diagnostics NGS Based Diagnostics Product Offered
11.8.3 Paradigm Diagnostics NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Paradigm Diagnostics Main Business Overview
11.8.5 Paradigm Diagnostics Latest Developments
11.9 Innogene Kalbiotech
11.9.1 Innogene Kalbiotech Company Information
11.9.2 Innogene Kalbiotech NGS Based Diagnostics Product Offered
11.9.3 Innogene Kalbiotech NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Innogene Kalbiotech Main Business Overview
11.9.5 Innogene Kalbiotech Latest Developments
11.10 Admera Health
11.10.1 Admera Health Company Information
11.10.2 Admera Health NGS Based Diagnostics Product Offered
11.10.3 Admera Health NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Admera Health Main Business Overview
11.10.5 Admera Health Latest Developments
11.11 AITbiotech
11.11.1 AITbiotech Company Information
11.11.2 AITbiotech NGS Based Diagnostics Product Offered
11.11.3 AITbiotech NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 AITbiotech Main Business Overview
11.11.5 AITbiotech Latest Developments
11.12 Centogene
11.12.1 Centogene Company Information
11.12.2 Centogene NGS Based Diagnostics Product Offered
11.12.3 Centogene NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Centogene Main Business Overview
11.12.5 Centogene Latest Developments
11.13 Phalanx Biotech Group
11.13.1 Phalanx Biotech Group Company Information
11.13.2 Phalanx Biotech Group NGS Based Diagnostics Product Offered
11.13.3 Phalanx Biotech Group NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Phalanx Biotech Group Main Business Overview
11.13.5 Phalanx Biotech Group Latest Developments
11.14 iGenomX
11.14.1 iGenomX Company Information
11.14.2 iGenomX NGS Based Diagnostics Product Offered
11.14.3 iGenomX NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 iGenomX Main Business Overview
11.14.5 iGenomX Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global NGS Based Diagnostics Market Size 2019-2030
2.1.2 NGS Based Diagnostics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 NGS Based Diagnostics Segment by Type
2.2.1 DNA Sequencing
2.2.2 RNA Sequencing
2.2.3 Whole Genome Sequencing
2.2.4 Whole Exome Sequencing
2.2.5 Other
2.3 NGS Based Diagnostics Market Size by Type
2.3.1 NGS Based Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global NGS Based Diagnostics Market Size Market Share by Type (2019-2024)
2.4 NGS Based Diagnostics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Academics/Research Institutions
2.5 NGS Based Diagnostics Market Size by Application
2.5.1 NGS Based Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global NGS Based Diagnostics Market Size Market Share by Application (2019-2024)
3 NGS BASED DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 NGS Based Diagnostics Market Size Market Share by Players
3.1.1 Global NGS Based Diagnostics Revenue by Players (2019-2024)
3.1.2 Global NGS Based Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global NGS Based Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NGS BASED DIAGNOSTICS BY REGIONS
4.1 NGS Based Diagnostics Market Size by Regions (2019-2024)
4.2 Americas NGS Based Diagnostics Market Size Growth (2019-2024)
4.3 APAC NGS Based Diagnostics Market Size Growth (2019-2024)
4.4 Europe NGS Based Diagnostics Market Size Growth (2019-2024)
4.5 Middle East & Africa NGS Based Diagnostics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas NGS Based Diagnostics Market Size by Country (2019-2024)
5.2 Americas NGS Based Diagnostics Market Size by Type (2019-2024)
5.3 Americas NGS Based Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC NGS Based Diagnostics Market Size by Region (2019-2024)
6.2 APAC NGS Based Diagnostics Market Size by Type (2019-2024)
6.3 APAC NGS Based Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe NGS Based Diagnostics by Country (2019-2024)
7.2 Europe NGS Based Diagnostics Market Size by Type (2019-2024)
7.3 Europe NGS Based Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa NGS Based Diagnostics by Region (2019-2024)
8.2 Middle East & Africa NGS Based Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa NGS Based Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NGS BASED DIAGNOSTICS MARKET FORECAST
10.1 Global NGS Based Diagnostics Forecast by Regions (2025-2030)
10.1.1 Global NGS Based Diagnostics Forecast by Regions (2025-2030)
10.1.2 Americas NGS Based Diagnostics Forecast
10.1.3 APAC NGS Based Diagnostics Forecast
10.1.4 Europe NGS Based Diagnostics Forecast
10.1.5 Middle East & Africa NGS Based Diagnostics Forecast
10.2 Americas NGS Based Diagnostics Forecast by Country (2025-2030)
10.2.1 United States NGS Based Diagnostics Market Forecast
10.2.2 Canada NGS Based Diagnostics Market Forecast
10.2.3 Mexico NGS Based Diagnostics Market Forecast
10.2.4 Brazil NGS Based Diagnostics Market Forecast
10.3 APAC NGS Based Diagnostics Forecast by Region (2025-2030)
10.3.1 China NGS Based Diagnostics Market Forecast
10.3.2 Japan NGS Based Diagnostics Market Forecast
10.3.3 Korea NGS Based Diagnostics Market Forecast
10.3.4 Southeast Asia NGS Based Diagnostics Market Forecast
10.3.5 India NGS Based Diagnostics Market Forecast
10.3.6 Australia NGS Based Diagnostics Market Forecast
10.4 Europe NGS Based Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany NGS Based Diagnostics Market Forecast
10.4.2 France NGS Based Diagnostics Market Forecast
10.4.3 UK NGS Based Diagnostics Market Forecast
10.4.4 Italy NGS Based Diagnostics Market Forecast
10.4.5 Russia NGS Based Diagnostics Market Forecast
10.5 Middle East & Africa NGS Based Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt NGS Based Diagnostics Market Forecast
10.5.2 South Africa NGS Based Diagnostics Market Forecast
10.5.3 Israel NGS Based Diagnostics Market Forecast
10.5.4 Turkey NGS Based Diagnostics Market Forecast
10.5.5 GCC Countries NGS Based Diagnostics Market Forecast
10.6 Global NGS Based Diagnostics Forecast by Type (2025-2030)
10.7 Global NGS Based Diagnostics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Janssen
11.1.1 Janssen Company Information
11.1.2 Janssen NGS Based Diagnostics Product Offered
11.1.3 Janssen NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Janssen Main Business Overview
11.1.5 Janssen Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche NGS Based Diagnostics Product Offered
11.2.3 Roche NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Qiagen
11.3.1 Qiagen Company Information
11.3.2 Qiagen NGS Based Diagnostics Product Offered
11.3.3 Qiagen NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Qiagen Main Business Overview
11.3.5 Qiagen Latest Developments
11.4 ThermoFisher Scientific
11.4.1 ThermoFisher Scientific Company Information
11.4.2 ThermoFisher Scientific NGS Based Diagnostics Product Offered
11.4.3 ThermoFisher Scientific NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 ThermoFisher Scientific Main Business Overview
11.4.5 ThermoFisher Scientific Latest Developments
11.5 Oxford Gene Technology
11.5.1 Oxford Gene Technology Company Information
11.5.2 Oxford Gene Technology NGS Based Diagnostics Product Offered
11.5.3 Oxford Gene Technology NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Oxford Gene Technology Main Business Overview
11.5.5 Oxford Gene Technology Latest Developments
11.6 Illumina
11.6.1 Illumina Company Information
11.6.2 Illumina NGS Based Diagnostics Product Offered
11.6.3 Illumina NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Illumina Main Business Overview
11.6.5 Illumina Latest Developments
11.7 Pacific Biosciences
11.7.1 Pacific Biosciences Company Information
11.7.2 Pacific Biosciences NGS Based Diagnostics Product Offered
11.7.3 Pacific Biosciences NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Pacific Biosciences Main Business Overview
11.7.5 Pacific Biosciences Latest Developments
11.8 Paradigm Diagnostics
11.8.1 Paradigm Diagnostics Company Information
11.8.2 Paradigm Diagnostics NGS Based Diagnostics Product Offered
11.8.3 Paradigm Diagnostics NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Paradigm Diagnostics Main Business Overview
11.8.5 Paradigm Diagnostics Latest Developments
11.9 Innogene Kalbiotech
11.9.1 Innogene Kalbiotech Company Information
11.9.2 Innogene Kalbiotech NGS Based Diagnostics Product Offered
11.9.3 Innogene Kalbiotech NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Innogene Kalbiotech Main Business Overview
11.9.5 Innogene Kalbiotech Latest Developments
11.10 Admera Health
11.10.1 Admera Health Company Information
11.10.2 Admera Health NGS Based Diagnostics Product Offered
11.10.3 Admera Health NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Admera Health Main Business Overview
11.10.5 Admera Health Latest Developments
11.11 AITbiotech
11.11.1 AITbiotech Company Information
11.11.2 AITbiotech NGS Based Diagnostics Product Offered
11.11.3 AITbiotech NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 AITbiotech Main Business Overview
11.11.5 AITbiotech Latest Developments
11.12 Centogene
11.12.1 Centogene Company Information
11.12.2 Centogene NGS Based Diagnostics Product Offered
11.12.3 Centogene NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Centogene Main Business Overview
11.12.5 Centogene Latest Developments
11.13 Phalanx Biotech Group
11.13.1 Phalanx Biotech Group Company Information
11.13.2 Phalanx Biotech Group NGS Based Diagnostics Product Offered
11.13.3 Phalanx Biotech Group NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Phalanx Biotech Group Main Business Overview
11.13.5 Phalanx Biotech Group Latest Developments
11.14 iGenomX
11.14.1 iGenomX Company Information
11.14.2 iGenomX NGS Based Diagnostics Product Offered
11.14.3 iGenomX NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 iGenomX Main Business Overview
11.14.5 iGenomX Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. NGS Based Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of DNA Sequencing
Table 3. Major Players of RNA Sequencing
Table 4. Major Players of Whole Genome Sequencing
Table 5. Major Players of Whole Exome Sequencing
Table 6. Major Players of Other
Table 7. NGS Based Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global NGS Based Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global NGS Based Diagnostics Market Size Market Share by Type (2019-2024)
Table 10. NGS Based Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global NGS Based Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global NGS Based Diagnostics Market Size Market Share by Application (2019-2024)
Table 13. Global NGS Based Diagnostics Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global NGS Based Diagnostics Revenue Market Share by Player (2019-2024)
Table 15. NGS Based Diagnostics Key Players Head office and Products Offered
Table 16. NGS Based Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global NGS Based Diagnostics Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global NGS Based Diagnostics Market Size Market Share by Regions (2019-2024)
Table 21. Global NGS Based Diagnostics Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global NGS Based Diagnostics Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas NGS Based Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas NGS Based Diagnostics Market Size Market Share by Country (2019-2024)
Table 25. Americas NGS Based Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas NGS Based Diagnostics Market Size Market Share by Type (2019-2024)
Table 27. Americas NGS Based Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas NGS Based Diagnostics Market Size Market Share by Application (2019-2024)
Table 29. APAC NGS Based Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC NGS Based Diagnostics Market Size Market Share by Region (2019-2024)
Table 31. APAC NGS Based Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC NGS Based Diagnostics Market Size Market Share by Type (2019-2024)
Table 33. APAC NGS Based Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC NGS Based Diagnostics Market Size Market Share by Application (2019-2024)
Table 35. Europe NGS Based Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe NGS Based Diagnostics Market Size Market Share by Country (2019-2024)
Table 37. Europe NGS Based Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe NGS Based Diagnostics Market Size Market Share by Type (2019-2024)
Table 39. Europe NGS Based Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe NGS Based Diagnostics Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa NGS Based Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa NGS Based Diagnostics Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa NGS Based Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa NGS Based Diagnostics Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa NGS Based Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa NGS Based Diagnostics Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of NGS Based Diagnostics
Table 48. Key Market Challenges & Risks of NGS Based Diagnostics
Table 49. Key Industry Trends of NGS Based Diagnostics
Table 50. Global NGS Based Diagnostics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global NGS Based Diagnostics Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global NGS Based Diagnostics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global NGS Based Diagnostics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Janssen Details, Company Type, NGS Based Diagnostics Area Served and Its Competitors
Table 55. Janssen NGS Based Diagnostics Product Offered
Table 56. Janssen NGS Based Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Janssen Main Business
Table 58. Janssen Latest Developments
Table 59. Roche Details, Company Type, NGS Based Diagnostics Area Served and Its Competitors
Table 60. Roche NGS Based Diagnostics Product Offered
Table 61. Roche Main Business
Table 62. Roche NGS Based Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Roche Latest Developments
Table 64. Qiagen Details, Company Type, NGS Based Diagnostics Area Served and Its Competitors
Table 65. Qiagen NGS Based Diagnostics Product Offered
Table 66. Qiagen Main Business
Table 67. Qiagen NGS Based Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Qiagen Latest Developments
Table 69. ThermoFisher Scientific Details, Company Type, NGS Based Diagnostics Area Served and Its Competitors
Table 70. ThermoFisher Scientific NGS Based Diagnostics Product Offered
Table 71. ThermoFisher Scientific Main Business
Table 72. ThermoFisher Scientific NGS Based Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. ThermoFisher Scientific Latest Developments
Table 74. Oxford Gene Technology Details, Company Type, NGS Based Diagnostics Area Served and Its Competitors
Table 75. Oxford Gene Technology NGS Based Diagnostics Product Offered
Table 76. Oxford Gene Technology Main Business
Table 77. Oxford Gene Technology NGS Based Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Oxford Gene Technology Latest Developments
Table 79. Illumina Details, Company Type, NGS Based Diagnostics Area Served and Its Competitors
Table 80. Illumina NGS Based Diagnostics Product Offered
Table 81. Illumina Main Business
Table 82. Illumina NGS Based Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Illumina Latest Developments
Table 84. Pacific Biosciences Details, Company Type, NGS Based Diagnostics Area Served and Its Competitors
Table 85. Pacific Biosciences NGS Based Diagnostics Product Offered
Table 86. Pacific Biosciences Main Business
Table 87. Pacific Biosciences NGS Based Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Pacific Biosciences Latest Developments
Table 89. Paradigm Diagnostics Details, Company Type, NGS Based Diagnostics Area Served and Its Competitors
Table 90. Paradigm Diagnostics NGS Based Diagnostics Product Offered
Table 91. Paradigm Diagnostics Main Business
Table 92. Paradigm Diagnostics NGS Based Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Paradigm Diagnostics Latest Developments
Table 94. Innogene Kalbiotech Details, Company Type, NGS Based Diagnostics Area Served and Its Competitors
Table 95. Innogene Kalbiotech NGS Based Diagnostics Product Offered
Table 96. Innogene Kalbiotech Main Business
Table 97. Innogene Kalbiotech NGS Based Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Innogene Kalbiotech Latest Developments
Table 99. Admera Health Details, Company Type, NGS Based Diagnostics Area Served and Its Competitors
Table 100. Admera Health NGS Based Diagnostics Product Offered
Table 101. Admera Health Main Business
Table 102. Admera Health NGS Based Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Admera Health Latest Developments
Table 104. AITbiotech Details, Company Type, NGS Based Diagnostics Area Served and Its Competitors
Table 105. AITbiotech NGS Based Diagnostics Product Offered
Table 106. AITbiotech NGS Based Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. AITbiotech Main Business
Table 108. AITbiotech Latest Developments
Table 109. Centogene Details, Company Type, NGS Based Diagnostics Area Served and Its Competitors
Table 110. Centogene NGS Based Diagnostics Product Offered
Table 111. Centogene Main Business
Table 112. Centogene NGS Based Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 113. Centogene Latest Developments
Table 114. Phalanx Biotech Group Details, Company Type, NGS Based Diagnostics Area Served and Its Competitors
Table 115. Phalanx Biotech Group NGS Based Diagnostics Product Offered
Table 116. Phalanx Biotech Group Main Business
Table 117. Phalanx Biotech Group NGS Based Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 118. Phalanx Biotech Group Latest Developments
Table 119. iGenomX Details, Company Type, NGS Based Diagnostics Area Served and Its Competitors
Table 120. iGenomX NGS Based Diagnostics Product Offered
Table 121. iGenomX Main Business
Table 122. iGenomX NGS Based Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 123. iGenomX Latest Developments
Table 1. NGS Based Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of DNA Sequencing
Table 3. Major Players of RNA Sequencing
Table 4. Major Players of Whole Genome Sequencing
Table 5. Major Players of Whole Exome Sequencing
Table 6. Major Players of Other
Table 7. NGS Based Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global NGS Based Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global NGS Based Diagnostics Market Size Market Share by Type (2019-2024)
Table 10. NGS Based Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global NGS Based Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global NGS Based Diagnostics Market Size Market Share by Application (2019-2024)
Table 13. Global NGS Based Diagnostics Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global NGS Based Diagnostics Revenue Market Share by Player (2019-2024)
Table 15. NGS Based Diagnostics Key Players Head office and Products Offered
Table 16. NGS Based Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global NGS Based Diagnostics Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global NGS Based Diagnostics Market Size Market Share by Regions (2019-2024)
Table 21. Global NGS Based Diagnostics Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global NGS Based Diagnostics Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas NGS Based Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas NGS Based Diagnostics Market Size Market Share by Country (2019-2024)
Table 25. Americas NGS Based Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas NGS Based Diagnostics Market Size Market Share by Type (2019-2024)
Table 27. Americas NGS Based Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas NGS Based Diagnostics Market Size Market Share by Application (2019-2024)
Table 29. APAC NGS Based Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC NGS Based Diagnostics Market Size Market Share by Region (2019-2024)
Table 31. APAC NGS Based Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC NGS Based Diagnostics Market Size Market Share by Type (2019-2024)
Table 33. APAC NGS Based Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC NGS Based Diagnostics Market Size Market Share by Application (2019-2024)
Table 35. Europe NGS Based Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe NGS Based Diagnostics Market Size Market Share by Country (2019-2024)
Table 37. Europe NGS Based Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe NGS Based Diagnostics Market Size Market Share by Type (2019-2024)
Table 39. Europe NGS Based Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe NGS Based Diagnostics Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa NGS Based Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa NGS Based Diagnostics Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa NGS Based Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa NGS Based Diagnostics Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa NGS Based Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa NGS Based Diagnostics Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of NGS Based Diagnostics
Table 48. Key Market Challenges & Risks of NGS Based Diagnostics
Table 49. Key Industry Trends of NGS Based Diagnostics
Table 50. Global NGS Based Diagnostics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global NGS Based Diagnostics Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global NGS Based Diagnostics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global NGS Based Diagnostics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Janssen Details, Company Type, NGS Based Diagnostics Area Served and Its Competitors
Table 55. Janssen NGS Based Diagnostics Product Offered
Table 56. Janssen NGS Based Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Janssen Main Business
Table 58. Janssen Latest Developments
Table 59. Roche Details, Company Type, NGS Based Diagnostics Area Served and Its Competitors
Table 60. Roche NGS Based Diagnostics Product Offered
Table 61. Roche Main Business
Table 62. Roche NGS Based Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Roche Latest Developments
Table 64. Qiagen Details, Company Type, NGS Based Diagnostics Area Served and Its Competitors
Table 65. Qiagen NGS Based Diagnostics Product Offered
Table 66. Qiagen Main Business
Table 67. Qiagen NGS Based Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Qiagen Latest Developments
Table 69. ThermoFisher Scientific Details, Company Type, NGS Based Diagnostics Area Served and Its Competitors
Table 70. ThermoFisher Scientific NGS Based Diagnostics Product Offered
Table 71. ThermoFisher Scientific Main Business
Table 72. ThermoFisher Scientific NGS Based Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. ThermoFisher Scientific Latest Developments
Table 74. Oxford Gene Technology Details, Company Type, NGS Based Diagnostics Area Served and Its Competitors
Table 75. Oxford Gene Technology NGS Based Diagnostics Product Offered
Table 76. Oxford Gene Technology Main Business
Table 77. Oxford Gene Technology NGS Based Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Oxford Gene Technology Latest Developments
Table 79. Illumina Details, Company Type, NGS Based Diagnostics Area Served and Its Competitors
Table 80. Illumina NGS Based Diagnostics Product Offered
Table 81. Illumina Main Business
Table 82. Illumina NGS Based Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Illumina Latest Developments
Table 84. Pacific Biosciences Details, Company Type, NGS Based Diagnostics Area Served and Its Competitors
Table 85. Pacific Biosciences NGS Based Diagnostics Product Offered
Table 86. Pacific Biosciences Main Business
Table 87. Pacific Biosciences NGS Based Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Pacific Biosciences Latest Developments
Table 89. Paradigm Diagnostics Details, Company Type, NGS Based Diagnostics Area Served and Its Competitors
Table 90. Paradigm Diagnostics NGS Based Diagnostics Product Offered
Table 91. Paradigm Diagnostics Main Business
Table 92. Paradigm Diagnostics NGS Based Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Paradigm Diagnostics Latest Developments
Table 94. Innogene Kalbiotech Details, Company Type, NGS Based Diagnostics Area Served and Its Competitors
Table 95. Innogene Kalbiotech NGS Based Diagnostics Product Offered
Table 96. Innogene Kalbiotech Main Business
Table 97. Innogene Kalbiotech NGS Based Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Innogene Kalbiotech Latest Developments
Table 99. Admera Health Details, Company Type, NGS Based Diagnostics Area Served and Its Competitors
Table 100. Admera Health NGS Based Diagnostics Product Offered
Table 101. Admera Health Main Business
Table 102. Admera Health NGS Based Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Admera Health Latest Developments
Table 104. AITbiotech Details, Company Type, NGS Based Diagnostics Area Served and Its Competitors
Table 105. AITbiotech NGS Based Diagnostics Product Offered
Table 106. AITbiotech NGS Based Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. AITbiotech Main Business
Table 108. AITbiotech Latest Developments
Table 109. Centogene Details, Company Type, NGS Based Diagnostics Area Served and Its Competitors
Table 110. Centogene NGS Based Diagnostics Product Offered
Table 111. Centogene Main Business
Table 112. Centogene NGS Based Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 113. Centogene Latest Developments
Table 114. Phalanx Biotech Group Details, Company Type, NGS Based Diagnostics Area Served and Its Competitors
Table 115. Phalanx Biotech Group NGS Based Diagnostics Product Offered
Table 116. Phalanx Biotech Group Main Business
Table 117. Phalanx Biotech Group NGS Based Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 118. Phalanx Biotech Group Latest Developments
Table 119. iGenomX Details, Company Type, NGS Based Diagnostics Area Served and Its Competitors
Table 120. iGenomX NGS Based Diagnostics Product Offered
Table 121. iGenomX Main Business
Table 122. iGenomX NGS Based Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 123. iGenomX Latest Developments
LIST OF FIGURES
Figure 1. NGS Based Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global NGS Based Diagnostics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. NGS Based Diagnostics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. NGS Based Diagnostics Sales Market Share by Country/Region (2023)
Figure 8. NGS Based Diagnostics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global NGS Based Diagnostics Market Size Market Share by Type in 2023
Figure 10. NGS Based Diagnostics in Hospitals
Figure 11. Global NGS Based Diagnostics Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. NGS Based Diagnostics in Clinics
Figure 13. Global NGS Based Diagnostics Market: Clinics (2019-2024) & ($ Millions)
Figure 14. NGS Based Diagnostics in Academics/Research Institutions
Figure 15. Global NGS Based Diagnostics Market: Academics/Research Institutions (2019-2024) & ($ Millions)
Figure 16. Global NGS Based Diagnostics Market Size Market Share by Application in 2023
Figure 17. Global NGS Based Diagnostics Revenue Market Share by Player in 2023
Figure 18. Global NGS Based Diagnostics Market Size Market Share by Regions (2019-2024)
Figure 19. Americas NGS Based Diagnostics Market Size 2019-2024 ($ Millions)
Figure 20. APAC NGS Based Diagnostics Market Size 2019-2024 ($ Millions)
Figure 21. Europe NGS Based Diagnostics Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa NGS Based Diagnostics Market Size 2019-2024 ($ Millions)
Figure 23. Americas NGS Based Diagnostics Value Market Share by Country in 2023
Figure 24. United States NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC NGS Based Diagnostics Market Size Market Share by Region in 2023
Figure 29. APAC NGS Based Diagnostics Market Size Market Share by Type in 2023
Figure 30. APAC NGS Based Diagnostics Market Size Market Share by Application in 2023
Figure 31. China NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 35. India NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe NGS Based Diagnostics Market Size Market Share by Country in 2023
Figure 38. Europe NGS Based Diagnostics Market Size Market Share by Type (2019-2024)
Figure 39. Europe NGS Based Diagnostics Market Size Market Share by Application (2019-2024)
Figure 40. Germany NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 41. France NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa NGS Based Diagnostics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa NGS Based Diagnostics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa NGS Based Diagnostics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 54. APAC NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 55. Europe NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 57. United States NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 58. Canada NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 59. Mexico NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 60. Brazil NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 61. China NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 62. Japan NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 63. Korea NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 65. India NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 66. Australia NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 67. Germany NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 68. France NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 69. UK NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 70. Italy NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 71. Russia NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 72. Spain NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 73. Egypt NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 74. South Africa NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 75. Israel NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 76. Turkey NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 78. Global NGS Based Diagnostics Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global NGS Based Diagnostics Market Size Market Share Forecast by Application (2025-2030)
Figure 1. NGS Based Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global NGS Based Diagnostics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. NGS Based Diagnostics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. NGS Based Diagnostics Sales Market Share by Country/Region (2023)
Figure 8. NGS Based Diagnostics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global NGS Based Diagnostics Market Size Market Share by Type in 2023
Figure 10. NGS Based Diagnostics in Hospitals
Figure 11. Global NGS Based Diagnostics Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. NGS Based Diagnostics in Clinics
Figure 13. Global NGS Based Diagnostics Market: Clinics (2019-2024) & ($ Millions)
Figure 14. NGS Based Diagnostics in Academics/Research Institutions
Figure 15. Global NGS Based Diagnostics Market: Academics/Research Institutions (2019-2024) & ($ Millions)
Figure 16. Global NGS Based Diagnostics Market Size Market Share by Application in 2023
Figure 17. Global NGS Based Diagnostics Revenue Market Share by Player in 2023
Figure 18. Global NGS Based Diagnostics Market Size Market Share by Regions (2019-2024)
Figure 19. Americas NGS Based Diagnostics Market Size 2019-2024 ($ Millions)
Figure 20. APAC NGS Based Diagnostics Market Size 2019-2024 ($ Millions)
Figure 21. Europe NGS Based Diagnostics Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa NGS Based Diagnostics Market Size 2019-2024 ($ Millions)
Figure 23. Americas NGS Based Diagnostics Value Market Share by Country in 2023
Figure 24. United States NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC NGS Based Diagnostics Market Size Market Share by Region in 2023
Figure 29. APAC NGS Based Diagnostics Market Size Market Share by Type in 2023
Figure 30. APAC NGS Based Diagnostics Market Size Market Share by Application in 2023
Figure 31. China NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 35. India NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe NGS Based Diagnostics Market Size Market Share by Country in 2023
Figure 38. Europe NGS Based Diagnostics Market Size Market Share by Type (2019-2024)
Figure 39. Europe NGS Based Diagnostics Market Size Market Share by Application (2019-2024)
Figure 40. Germany NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 41. France NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa NGS Based Diagnostics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa NGS Based Diagnostics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa NGS Based Diagnostics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country NGS Based Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 54. APAC NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 55. Europe NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 57. United States NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 58. Canada NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 59. Mexico NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 60. Brazil NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 61. China NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 62. Japan NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 63. Korea NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 65. India NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 66. Australia NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 67. Germany NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 68. France NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 69. UK NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 70. Italy NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 71. Russia NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 72. Spain NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 73. Egypt NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 74. South Africa NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 75. Israel NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 76. Turkey NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries NGS Based Diagnostics Market Size 2025-2030 ($ Millions)
Figure 78. Global NGS Based Diagnostics Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global NGS Based Diagnostics Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Cellulite Reduction Devices Market Growth 2025-2031
US$ 3,660.00
March 2025
124 pages
Global Adenosine Triphosphate (ATP) Swab Test Kit Market Growth 2025-2031
US$ 3,660.00
May 2025
92 pages
Global Minimally Invasive Bariatric Surgery Equipment Market Growth 2023-2029
US$ 3,660.00
February 2023
105 pages
Global Floor-standing Platelet Laboratory Incubator Market Growth 2023-2029
US$ 3,660.00
March 2023
117 pages
Global Biologics Drug Discovery Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
118 pages
